Monoclonal Antibodies

Abstract Background: Despite the growing importance of polypeptide-based drugs in clinical therapy, studies investigating the stability of their freeze-dried formulations...

Abstract High dose biologic drug products (DPs) have become a common trend for the treatment of chronic diseases across a...

Press Release Waukegan, IL – Pfanstiehl, a global leader in high-purity excipient manufacturing, announces the release of its High Purity Low...

Abstract Despite remarkable advances in cancer therapeutics, conventional treatments still face significant hurdles, including systemic toxicity, poor tumor specificity, multidrug...

Abstract Protein-based drugs are prone to both physical and chemical instability in aqueous solutions. Surfactants, such as polysorbates (PS), are...

Abstract Peptide therapeutics are important in healthcare owing to their high target specificity, therapeutic efficacy, and relatively low side effect...

Abstract With continued interest in high concentration monoclonal antibody drug products to meet subcutaneous administration requirements, there is heightened attention...

Abstract There are limited options available for safe and effective non-hormonal contraceptives or methods that block sexually transmitted diseases such...

Abstract Among the various pharmaceutical forms, tablets offer numerous advantages, like ease of administration, cost-effectiveness in production, and better stability...

Monoclonal antibodies require careful formulation due to their inherent stability limitations. Polysorbates are commonly used to stabilize mAbs, but they...